1.1 Articolo in rivista

1.1 Articolo in rivista: [16773] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 7.741 a 7.760 di 16.773

ELF REGIMEN IN ADVANCED GASTROINTESTINAL MALIGNANCIES - AN ANALYSIS OF ITS CLINICAL EFFECTIVENESS AND TOXICITY

1994-01-01 Gebbia, V; Sciume, C; Cannata, G; Curto, G; Valenza, R; Testa, A; Cipolla, C; Cusumano, A; Verderame, F; Fortunato, S; Digesu, G; Leo, P; Gebbia, N

Mitomycin «C» and Vinorelbine as Second Line Chemotherapy for Metastatic Breast Carcinoma

1994-01-01 Agostara, Biagio; Gebbia, Vittorio; Testa, Antonio; Cusimano, Maria Pia; Gebbia, Nicolò; Callari, Angela Maria

A prospective randomized trial of thymopentin versus granulocyte--colony stimulating factor with or without thymopentin in the prevention of febrile episodes in cancer patients undergoing highly cytotoxic chemotherapy

1994-01-01 Gebbia, V; Valenza, R; Testa, A; Cannata, G; Borsellino, N; Gebbia, N

Combination Chemotherapy of 5-Fluorouracil, Epidoxorubicin and Mitomycin C in the Palliative Treatment of Locally Advanced and/or Metastatic Adenocarcinoma of the Stomach

1994-01-01 Gebbia, V.; Testa, A.; Valenza, R.; Latteri, M.; Bajardi, G.; Mastrandrea, G.; Cipolla, C.; Pischedda, G.; Curto, G.; Cannata, G.; Gebbia, N.; Florena, M.

Vinorelbine plus cisplatinum for the treatment of stage IIIB and IV non small cell lung carcinoma

1994-01-01 Gebbia, V; Caruso, M; Valenza, R; Testa, A; Cannata, G; Verderame, F; Cipolla, C; Curto, G; Oliveri, D; Chiarenza, M

Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck

1994-01-01 Gebbia, V; Valenza, R; Testa, A; Borsellino, N; Cannata, G; Restivo, S; Speciale, R; Ingria, F; Spadafora, G; Gebbia, N.

Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trial

1994-01-01 Gebbia, V; Cannata, G; Testa, A; Curto, G; Valenza, R; Cipolla, C; Latteri, Ma; Gebbia, N.

Weekly levofolinic acid and 5-fluorouracil plus hydroxyurea in metastatic gastrointestinal adenocarcinomas

1994-01-01 Gebbia, V.; Valenza, R.; Testa, A.; Cipolla, C.; Latteri, M.; Curto, G.; Comande, S.; Buccellato, C.; Gebbia, N.

A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group

1995-01-01 Di Bartolomeo, M; Bajetta, E; Bochicchio, Am; Carnaghi, C; Somma, L; Mazzaferro, V; Visini, M; Gebbia, V; Tumolo, S; Ballatore, P.

Phase II study of the etoposide, leucovorin and fluorouracil combination for patients with advanced gastric cancer unsuitable for aggressive chemotherapy

1995-01-01 di Bartolomeo, M; Bajetta, E; de Braud, F; Bochicchio, Am; Gebbia, V; Bozzetti, F; Doci, R; Bonfanti, G; Cozzaglio, L

CISPLATIN PLUS VP16 AS SALVAGE TREATMENT FOR ADVANCED BREAST-CARCINOMA RESISTANT OR RECURRENT AFTER 1ST LINE CHEMOTHERAPY FOR METASTATIC DISEASE

1995-01-01 Ferrero, B; Gebbia, V; Cannata, G; Giuffre, S; Valenza, R; Testa, A; Tirrito, M; Gebbia, N

Perineural infiltration by cutaneous squamous cell carcinomas of the head and neck

1995-01-01 Di Gregorio, C; Gebbia, V; Florena, Am; Franco, V; Moschella, F.

Vinorelbine plus cisplatin in recurrent or previously untreated unresectable squamous cell carcinoma of the head and neck

1995-01-01 Gebbia, V; Testa, A; Di Gregorio, C; Ingria, F; Valenza, R; Cannata, G; Moschella, F; Restivo, G; Gebbia, N.

Primary extranodal non-Hodgkin lymphomas of the uterus and the breast: report of three cases

1995-01-01 Latteri, Ma; Cipolla, C; Gebbia, V; Lampasona, G; Amato, C; Gebbia, N.

Laevofolinic acid, 5-fluorouracil, cyclophosphamide and escalating doses of epirubicin with granulocyte colony-stimulating factor support in locally advanced and/or metastatic breast carcinoma: a phase I-II study of the Southern Italy Oncology Group (GOIM)

1995-01-01 Colucci, G; Romito, S; Gebbia, V; Pacilio, G; Giotta, F; Testa, A; Pezzella, G; Durini, E; Agostara, B; Cariello, S

Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial

1995-01-01 Gebbia, V; Testa, A; Valenza, R; Cannata, G; Tirrito, Ml; Gebbia, N.

An I.T.M.O. group study on second-line treatment in advanced epithelial ovarian cancer: an attempt to identify clinical and biological factors determining prognosis

1995-01-01 Di Leo, A; Bajetta, E; Biganzoli, L; Bohm, S; Mariani, L; Mènard, S; Pilotti, S; Fabbiani, M; Gebbia, V; Oriana, S; Et, Al.

Thyroid cancer: different outcomes to chemotherapy according to tumour histology

1995-01-01 Biganzoli, L; Gebbia, V; Maiorino, L; Caraci, P; Iirillo, A.

Treatment of recurrent and/or metastatic squamous cell head and neck carcinoma with a combination of vinorelbine, cisplatin, and 5-fluorouracil: A multicenter phase II trial

1995-01-01 Gebbia, V.; Mantovani, G.; Agostara, B.; Contu, A.; Farris, A.; Colucci, G.; Cognetti, F.; Restivo, G.; Speciale, R.; Ferrero, B.; Testa, A.; Curreli, L.; Cardinale, A.; Bajetta, E.; Gebbia, N.

Usefulness of oral medroxyprogesterone acetate in the management of cancer-related cachexia-anorexia syndrome

1996-01-01 Testa, A; Gebbia, V; Borsellino, N; Valenza, R; Cannata, G; Tirrito, M; Verderame, F; Armata, M; Valerio, M; Gebbia, N

Titolo	Data di pubblicazione	Autore(i)
ELF REGIMEN IN ADVANCED GASTROINTESTINAL MALIGNANCIES - AN ANALYSIS OF ITS CLINICAL EFFECTIVENESS AND TOXICITY	1-gen-1994	Gebbia, V; Sciume, C; Cannata, G; Curto, G; Valenza, R; Testa, A; Cipolla, C; Cusumano, A; Verderame, F; Fortunato, S; Digesu, G; Leo, P; Gebbia, N
Mitomycin «C» and Vinorelbine as Second Line Chemotherapy for Metastatic Breast Carcinoma	1-gen-1994	Agostara, Biagio; Gebbia, Vittorio; Testa, Antonio; Cusimano, Maria Pia; Gebbia, Nicolò; Callari, Angela Maria
A prospective randomized trial of thymopentin versus granulocyte--colony stimulating factor with or without thymopentin in the prevention of febrile episodes in cancer patients undergoing highly cytotoxic chemotherapy	1-gen-1994	Gebbia, V; Valenza, R; Testa, A; Cannata, G; Borsellino, N; Gebbia, N
Combination Chemotherapy of 5-Fluorouracil, Epidoxorubicin and Mitomycin C in the Palliative Treatment of Locally Advanced and/or Metastatic Adenocarcinoma of the Stomach	1-gen-1994	Gebbia, V.; Testa, A.; Valenza, R.; Latteri, M.; Bajardi, G.; Mastrandrea, G.; Cipolla, C.; Pischedda, G.; Curto, G.; Cannata, G.; Gebbia, N.; Florena, M.
Vinorelbine plus cisplatinum for the treatment of stage IIIB and IV non small cell lung carcinoma	1-gen-1994	Gebbia, V; Caruso, M; Valenza, R; Testa, A; Cannata, G; Verderame, F; Cipolla, C; Curto, G; Oliveri, D; Chiarenza, M
Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck	1-gen-1994	Gebbia, V; Valenza, R; Testa, A; Borsellino, N; Cannata, G; Restivo, S; Speciale, R; Ingria, F; Spadafora, G; Gebbia, N.
Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Results of a prospective randomized trial	1-gen-1994	Gebbia, V; Cannata, G; Testa, A; Curto, G; Valenza, R; Cipolla, C; Latteri, Ma; Gebbia, N.
Weekly levofolinic acid and 5-fluorouracil plus hydroxyurea in metastatic gastrointestinal adenocarcinomas	1-gen-1994	Gebbia, V.; Valenza, R.; Testa, A.; Cipolla, C.; Latteri, M.; Curto, G.; Comande, S.; Buccellato, C.; Gebbia, N.
A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group	1-gen-1995	Di Bartolomeo, M; Bajetta, E; Bochicchio, Am; Carnaghi, C; Somma, L; Mazzaferro, V; Visini, M; Gebbia, V; Tumolo, S; Ballatore, P.
Phase II study of the etoposide, leucovorin and fluorouracil combination for patients with advanced gastric cancer unsuitable for aggressive chemotherapy	1-gen-1995	di Bartolomeo, M; Bajetta, E; de Braud, F; Bochicchio, Am; Gebbia, V; Bozzetti, F; Doci, R; Bonfanti, G; Cozzaglio, L
CISPLATIN PLUS VP16 AS SALVAGE TREATMENT FOR ADVANCED BREAST-CARCINOMA RESISTANT OR RECURRENT AFTER 1ST LINE CHEMOTHERAPY FOR METASTATIC DISEASE	1-gen-1995	Ferrero, B; Gebbia, V; Cannata, G; Giuffre, S; Valenza, R; Testa, A; Tirrito, M; Gebbia, N
Perineural infiltration by cutaneous squamous cell carcinomas of the head and neck	1-gen-1995	Di Gregorio, C; Gebbia, V; Florena, Am; Franco, V; Moschella, F.
Vinorelbine plus cisplatin in recurrent or previously untreated unresectable squamous cell carcinoma of the head and neck	1-gen-1995	Gebbia, V; Testa, A; Di Gregorio, C; Ingria, F; Valenza, R; Cannata, G; Moschella, F; Restivo, G; Gebbia, N.
Primary extranodal non-Hodgkin lymphomas of the uterus and the breast: report of three cases	1-gen-1995	Latteri, Ma; Cipolla, C; Gebbia, V; Lampasona, G; Amato, C; Gebbia, N.
Laevofolinic acid, 5-fluorouracil, cyclophosphamide and escalating doses of epirubicin with granulocyte colony-stimulating factor support in locally advanced and/or metastatic breast carcinoma: a phase I-II study of the Southern Italy Oncology Group (GOIM)	1-gen-1995	Colucci, G; Romito, S; Gebbia, V; Pacilio, G; Giotta, F; Testa, A; Pezzella, G; Durini, E; Agostara, B; Cariello, S
Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial	1-gen-1995	Gebbia, V; Testa, A; Valenza, R; Cannata, G; Tirrito, Ml; Gebbia, N.
An I.T.M.O. group study on second-line treatment in advanced epithelial ovarian cancer: an attempt to identify clinical and biological factors determining prognosis	1-gen-1995	Di Leo, A; Bajetta, E; Biganzoli, L; Bohm, S; Mariani, L; Mènard, S; Pilotti, S; Fabbiani, M; Gebbia, V; Oriana, S; Et, Al.
Thyroid cancer: different outcomes to chemotherapy according to tumour histology	1-gen-1995	Biganzoli, L; Gebbia, V; Maiorino, L; Caraci, P; Iirillo, A.
Treatment of recurrent and/or metastatic squamous cell head and neck carcinoma with a combination of vinorelbine, cisplatin, and 5-fluorouracil: A multicenter phase II trial	1-gen-1995	Gebbia, V.; Mantovani, G.; Agostara, B.; Contu, A.; Farris, A.; Colucci, G.; Cognetti, F.; Restivo, G.; Speciale, R.; Ferrero, B.; Testa, A.; Curreli, L.; Cardinale, A.; Bajetta, E.; Gebbia, N.
Usefulness of oral medroxyprogesterone acetate in the management of cancer-related cachexia-anorexia syndrome	1-gen-1996	Testa, A; Gebbia, V; Borsellino, N; Valenza, R; Cannata, G; Tirrito, M; Verderame, F; Armata, M; Valerio, M; Gebbia, N

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 7.741 a 7.760 di 16.773

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext16772